Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

NCT01941316 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

78

Enrollment

NETWORK

Sponsor class

Conditions

Small Cell Lung Carcinoma
Non Small Cell Lung Carcinoma
Irinotecan Sensitive Cancers

Interventions

DRUG: Carfilzomib
DRUG: Irinotecan

Sponsor

Cancer Research and Biostatistics Clinical Trials Consortium

Collaborators

[object Object]
[object Object]